| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $12K | — |
| R&D Expense | $12.9M | +104.1% |
| SG&A Expense | $17.2M | +114.4% |
| Operating Income | -$30.0M | +39.5% |
| Pre-tax Income | -$18.4M | +62.2% |
| Income Tax | $30K | — |
| Net Income | -$18.5M | +62.2% |
| EPS (Basic) | -$1.15 | +65.4% |
| EPS (Diluted) | -$1.15 |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | -73.5% |
| Current Assets | $16.2M | -29.5% |
| Total Assets | $17.0M | -28.3% |
| Current Liabilities | $5.6M | +120.4% |
| Total Liabilities | $5.8M | +97.1% |
| Stockholders' Equity | $11.2M | -46.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.8M | -47.4% |
| Capital Expenditures | $277K | -12.3% |
| Investing Cash Flow | -$277K | +12.3% |
| Financing Cash Flow | $8.2M | +0.0% |
| Free Cash Flow | -$16.1M | -45.7% |
| +65.4% |